Search
for
Sort by
Research 511–540 of 1000+
- Cutaneous Sequelae After Burn Injury: Pruritus, Dyspigmentation and Malignancy—Mechanisms and Management
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- A Holistic Approach to Unravel Keloid Pathogenesis and Optimize Therapeutic Outcomes
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia
- Hematological ratios in pediatric patients with alopecia areata based on a nationwide retrospective cohort study
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Illness Perception, Emotional Distress, and Obsessive–Compulsive Symptomatology in Patients with Alopecia Areata: A Mediation Study
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Insights into the Diagnostics and Therapeutics of Alopecia Areata—An Indian Context
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Review of Promising Off-Label Use of Deucravacitinib
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- The Use of Light‐Based Therapies in the Treatment of Alopecia
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Update From Dermatology Nurses’ Association Convention 2025
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Scalp Involvement in Primary Cutaneous Lymphomas—An Update on Clinical Presentation, Diagnostics, and Management
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases